iSOFT Installs e-Prescribing at University Hospitals of Leicester

iSOFTiSOFT, a CSC company, has completed an initial implementation of its e-prescribing and medicines administration solution (ePMA) at the University Hospitals of Leicester NHS Trust, under moves to transform patient safety, clinical outcomes and operational performance.

The project was completed in five months, with the first phase focusing on the bone and marrow transplant unit, oncology and haematology wards, ahead of a roll-out across all wards and departments at the trust's three main hospitals.

The project follows an agreement in June that included iSOFT's ePMA and i.Pharmacy products. This gives Leicester a complete prescribing and medicines management solution to improve dispensing, stock control and further promote medicines good practice across the trust.

"With new and complex medicines being introduced almost on a daily basis, the risk of adverse interactions and clinical errors has increased exponentially," said Beverly Collett, the trust's associate medical director. "Given the sheer volume and complexity of drug information, it is impossible for prescribers to recall all of the potential interactions and their clinical significance. iSOFT's ePMA will support our clinical teams by improving communication and clarity of information, while reducing process complexities that can introduce clinical risk."

The trust is a long standing customer and uses a host of iSOFT patient, clinical and departmental solutions. "This is a clear sign that University Hospitals of Leicester continues to derive genuine value from its partnership with iSOFT," said Adrian Stevens, managing director of iSOFT's UK and Ireland business. "These latest innovations will allow it to build on systems that are familiar and trusted to further improve efficiency and deliver tangible benefits to patients."

iSOFT ePMA provides new opportunities to improve the communication of medicines related information between medical, nursing and clinical pharmacy teams. Advanced drug formulary management, underpinned by clinical and workflow based decision support, provides a highly effective environment to help improve a hospital's performance in relation to medicines. In-built reporting and data analysis tools provide executive and management visibility of performance to help proactively address areas of concern or promote good practice.

Proven at large acute and specialist hospitals in Australia and New Zealand, iSOFT ePMA is shown to halve adverse medication errors that can prolong a patient's stay by up to four days, and so block hospital beds and increase costs.

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 97,000 employees and reported revenue of $16.2 billion for the 12 months ended September 30, 2011.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...